EPIZYME, INC. Selling, General and Administrative Expense
EPIZYME, INC. reported Selling, General and Administrative Expense of $24.11 million for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2022-08-09
- EPIZYME, INC. selling, general and administrative expense for the quarter ending 2022-06-30 was $24.11M, a 28.86% decline year-over-year.
- EPIZYME, INC. selling, general and administrative expense for the quarter ending 2022-03-31 was $27.20M, a 25.29% decline year-over-year.
- EPIZYME, INC. selling, general and administrative expense for the quarter ending 2021-12-31 was $30.86M, a 11.87% decline year-over-year.
- EPIZYME, INC. selling, general and administrative expense for the quarter ending 2021-09-30 was $32.79M, a 7.25% increase year-over-year.
- EPIZYME, INC. selling, general and administrative expense for fiscal 2021 was $133.96M, a 7.01% increase from fiscal 2020.
- EPIZYME, INC. selling, general and administrative expense for fiscal 2020 was $125.18M, a 83.27% increase from fiscal 2019.
- EPIZYME, INC. selling, general and administrative expense for fiscal 2019 was $68.30M, a 55.33% increase from fiscal 2018.
- EPIZYME, INC. selling, general and administrative expense for fiscal 2018 was $43.97M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2022-06-30 | $24.11M 10-Q · filed 2022-08-09 | $51.31M 10-Q · filed 2022-08-09 | $82.17M derived: sum of 3 quarters · filed 2022-08-09 | $114.97M derived: sum of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | $27.20M 10-Q · filed 2022-05-10 | $58.06M derived: sum of 2 quarters · filed 2022-05-10 | $90.86M derived: sum of 3 quarters · filed 2022-05-10 | $124.75M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-12-31 | $30.86M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $63.65M derived: sum of 2 quarters · filed 2022-03-01 | $97.54M derived: sum of 3 quarters · filed 2022-08-09 | $133.96M 10-K · filed 2022-03-01 |
| 2021-09-30 | $32.79M 10-Q · filed 2021-11-09 | $66.68M derived: sum of 2 quarters · filed 2022-08-09 | $103.09M 10-Q · filed 2021-11-09 | $138.11M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-06-30 | $33.89M 10-Q · filed 2022-08-09 | $70.30M 10-Q · filed 2022-08-09 | $105.32M derived: sum of 3 quarters · filed 2022-08-09 | $135.89M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $36.41M 10-Q · filed 2022-05-10 | $71.43M derived: sum of 2 quarters · filed 2022-05-10 | $102.00M derived: sum of 3 quarters · filed 2022-05-10 | $134.66M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $35.02M 10-K · filed 2021-02-23 | $65.59M derived: sum of 2 quarters · filed 2021-11-09 | $98.25M derived: sum of 3 quarters · filed 2021-11-09 | $125.18M 10-K · filed 2022-03-01 |
| 2020-09-30 | $30.57M 10-Q · filed 2021-11-09 | $63.23M derived: sum of 2 quarters · filed 2021-11-09 | $90.16M 10-Q · filed 2021-11-09 | $113.69M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $32.66M 10-Q · filed 2021-08-09 | $59.58M 10-Q · filed 2021-08-09 | $83.12M derived: sum of 3 quarters · filed 2021-08-09 | $100.20M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $26.93M 10-Q · filed 2021-05-06 | $50.46M derived: sum of 2 quarters · filed 2021-05-06 | $67.55M derived: sum of 3 quarters · filed 2021-05-06 | $83.24M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $23.53M 10-K · filed 2021-02-23 | $40.62M derived: sum of 2 quarters · filed 2021-02-23 | $56.32M derived: sum of 3 quarters · filed 2021-02-23 | $68.30M 10-K · filed 2022-03-01 |
| 2019-09-30 | $17.09M 10-K · filed 2021-02-23 | $32.79M derived: sum of 2 quarters · filed 2021-02-23 | $44.77M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $15.70M 10-K · filed 2021-02-23 | $27.68M 10-Q · filed 2020-08-04 | ||
| 2019-03-31 | $11.99M 10-K · filed 2021-02-23 | |||
| 2018-12-31 | $43.97M 10-K · filed 2021-02-23 |